API PHARMA financials
A multi-period view of the public annual-account figures reported for API PHARMA, with comparable measures and links to available source documents.
Company overviewRegistry number
0805949739
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for API PHARMA
2025 versus 2024
- Operating line
- €52,678
- EBITDA
- €52,312
- Total assets
- €116,460
- Equity
- €69,569
+5.1%
+10.4%
+43.3%
+86.8%
EBITDA margin +99.3% · Equity ratio +59.7%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.